The invention is concerned with novel piperidine-amide derivatives of formula (I)
wherein R
1
, R
2
, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit L-CPT1 and may be used to treat diseases associated with L-CPT1.
这项发明涉及式(I)中的新型
哌啶酰胺衍
生物,其中R1、R2、X和Y如描述和权利要求中定义,并且其生理上可接受的盐和
酯。这些化合物抑制L-C
PT1,可用于治疗与L-C
PT1相关的疾病。